Navigation Links
CEL-SCI Corporation Reports First Quarter Financial Results
Date:2/14/2008

VIENNA, Va., Feb. 14 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (Amex: CVM) reports financial results for the first quarter fiscal year 2008, ending December 31, 2007.

Highlights:

-- Net loss for the three months ending December 31, 2007 was

approximately $1.84 million compared with an operating loss of

approximately $1.1 million during the quarter ending December 31,

2006.

-- The net loss per common share was at $0.02 during the quarter ending

December 31, 2007 compared with the net loss per common share of $0.01

for the quarter ending December 31, 2006.

-- During the three-month period ended December 31, 2007, research and

development expenses doubled compared to the three-month period ended

December 31, 2006. This is due to the increase in work for preparation

of the Phase III clinical study.

About CEL-SCI's Phase III Cancer Drug Multikine:

In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007. CEL-SCI is currently building a manufacturing facility for Multikine close to Baltimore, MD. Upon completion of the facility in the 3rd quarter of 2008, CEL-SCI will commence the Phase III clinical trial. Multikine appears to be the first non-toxic cancer drug.

Multikine, a patented defined mixture of naturally der
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEL-SCI Corporation Announces 2007 Financial Results
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
3. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
4. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
10. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
11. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... About Duchenne muscular dystrophy Duchenne ... affects the male population. It is characterized by ... caused due to mutations in the dystrophin gene, ... dystrophin (a protein essential for maintaining healthy muscle ... muscle function, causes loss of ambulation, harms the ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and Markets ... "Pharmaceutical Regulatory Affairs in China (Basel, Switzerland - November 26-27, ... seminar will provide a detailed overview of the key areas ... Hong Kong , Macau ... - All important aspects of gaining and ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
(Date:9/2/2015)... ... September 02, 2015 , ... In “Failure Lab: Weight Loss Surgery was ... August 25th, writer Akela Stanfield detailed her lifelong struggle with obesity that eventually led ... had always seen herself as someone who would lose weight through sheer self-control, the ...
(Date:9/2/2015)... Waltham, MA (PRWEB) , ... September 02, 2015 ... ... often get swamped with a large stream of mixed documents that include EOBs, ... the various documents, while extracting the data needed to reconcile their billing, with ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... clinical and academic partnership has earned international recognition as a premier center for ... that can cause sudden, catastrophic internal bleeding and stroke. , Cure HHT, ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... clinical staffing companies, has completed a recapitalization with new investment partners Beecken ... and Heritage Group each offer extensive expertise and connections within the healthcare ...
(Date:9/2/2015)... ... 02, 2015 , ... Amada Senior Care, premier provider of in-home care and ... Johnson County location. Amada franchise partners Mike and Mell Fleming came to the ... spent over 20 years in medical device sales while Mell spent over 30 years ...
Breaking Medicine News(10 mins):Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2
... Aug. 19 (HealthDay News) -- At 3 years of age, Pablo ... He also had frequent severe constipation, so much so that he ... of Alexandria, Va. Because of the prolapse, a condition in ... doctors worried that the boy, who is now 13, had cystic ...
... delicti is a plain flacon from among the possessions of ... exhibit in the permanent collection of the Egyptian Museum of ... the vessel may have held a deadly secret. This is ... Helmut Wiedenfeld from the university,s Pharmacology Institute just discovered. After ...
... (August 19, 2011) Antibiotics can help ward off serious ... catheters for their dialysis treatments. But if antibiotics are used ... to the drugs. A new randomized controlled clinical trial ... used to treat other serious infections may be a safe ...
... News) -- Cases of Legionnaire,s disease in the United States ... report shows. And while Legionnaires, disease is serious and ... for concern, most people recover with antibiotic treatment, officials said. ... Centers for Disease Control and Prevention rose from 1,110 in ...
... 18 (HealthDay News) -- Two gene variations that increase smokers, ... Smokers with the variants also tend to smoke more and ... Researchers at the Centre for Addiction and Mental Health in ... cancer and 443 current or former smokers without cancer. ...
... Society congratulates Dietrich Manzey, Maria Luz, Stefan Mueller, ... receiving the 2011 Human Factors Prize for their ... Assistance on Performance, Waorkload, Situation Awareness, and Acquisition ... is health-care ergonomics, broadly defined to include research ...
Cached Medicine News:Health News:Gluten-Free Set This Boy Free 2Health News:Deadly medication? 2Health News:Deadly medication? 3Health News:Acne-treating antibiotic cuts catheter infections in dialysis patients 2Health News:Cases of Legionnaire's Disease Tripled in 10 Years 2Health News:Gene Variants That Boost Lung Cancer Risk Identified 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 3Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: